Candel Therapeutics Inc (CADL)
7.97
+0.92
(+13.05%)
USD |
NASDAQ |
May 01, 16:00
7.78
-0.19
(-2.38%)
After-Hours: 18:35
Candel Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -16.40K% |
| September 30, 2022 | -28.03K% |
| June 30, 2022 | -13.38K% |
| March 31, 2022 | -2.82K% |
| December 31, 2021 | |
| September 30, 2021 | -52.14K% |
| Date | Value |
|---|---|
| June 30, 2021 | -55.10K% |
| March 31, 2021 | -14.45K% |
| December 31, 2020 | -33.80K% |
| September 30, 2020 | -8.24K% |
| June 30, 2020 | -9.28K% |
| March 31, 2020 | -5.72K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-55.10K%
Minimum
Jun 2021
-2.82K%
Maximum
Mar 2022
-21.76K%
Average
-14.45K%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Allurion Technologies Inc | -232.9% |
| AngioDynamics Inc | -249.7% |
| Eliem Therapeutics Inc | -- |
| Macrogenics Inc | -502.7% |
| GlycoMimetics Inc | -90.79K% |